Klivira
Request demo

Modernizing gGastro Eylea Prior Authorization Workflows

Klivira streamlines gGastro Eylea prior authorization, ensuring efficient processing for this critical specialty medication regardless of the originating EMR's primary specialty focus.

Managing prior authorizations for specialty medications like Eylea presents unique challenges, particularly when integrating with EMRs like gGastro, which are tailored for specific medical specialties. Revenue cycle leaders and PA coordinators require robust solutions that can abstract complex drug-specific requirements from EMR-specific workflows, ensuring timely patient access and optimized reimbursement. Klivira addresses this by providing a unified platform for automated PA.

Streamlining Eylea Prior Authorizations within gGastro Workflows

Klivira integrates directly with gGastro via ModMed APIs to intercept and process prior authorization requests for specialty medications like Eylea (aflibercept). While gGastro is tailored for gastroenterology, Klivira's platform is designed to identify and manage PA requirements for any ordered drug, ensuring that even atypical orders for a specific EMR are routed efficiently for medical necessity review and specialty pharmacy coordination.

Intelligent Data Extraction for Eylea from ModMed Gastro

Successful Eylea prior authorization hinges on comprehensive clinical documentation. Klivira leverages gGastro's structured and unstructured data, extracting critical information such as diagnosis codes (e.g., for wet AMD, DME), visual acuity, OCT findings, and prior treatment history. This ensures that all necessary supporting documentation is compiled for payer submission, regardless of where within the EMR these data points reside.

Navigating Medical vs. Pharmacy Benefit for Eylea

Eylea (aflibercept) is typically a buy-and-bill medication covered under the medical benefit. Klivira's platform accurately identifies this distinction, initiating the appropriate X12 278 transaction rather than a pharmacy benefit ePA (NCPDP SCRIPT). This precision ensures that prior authorization requests are submitted to the correct payer channel, minimizing rejections due to incorrect benefit determination.

Key Clinical Data Points for Eylea PA Automation

  • ICD-10 codes supporting FDA-approved indications (e.g., H35.32 for wet AMD, E11.3 for DME).
  • Visual acuity measurements and best-corrected visual acuity (BCVA).
  • Optical Coherence Tomography (OCT) findings, including central subfield thickness (CST) and presence of intraretinal fluid (IRF) or subretinal fluid (SRF).
  • Documentation of prior anti-VEGF therapy and response, if applicable.
  • Confirmation of patient eligibility and lack of contraindications.
  • Physician's attestation of medical necessity and treatment plan.

Automated Submission and Real-time Status for Aflibercept

Klivira automates the submission of Eylea prior authorizations through established ePA channels, including direct payer portals and X12 278 gateways. Post-submission, the platform provides real-time status updates, allowing PA coordinators to monitor approval progress without manual follow-up, thereby accelerating time-to-treatment for patients.

Optimizing Specialty Pharmacy and Buy-and-Bill Coordination

For drugs like Eylea, efficient coordination with specialty pharmacies and streamlined buy-and-bill processes are critical. Klivira's integration capabilities ensure that once PA is secured, the necessary information is relayed for drug acquisition and inventory management, bridging the gap between clinical approval and medication delivery.

Frequently asked questions

How does Klivira handle Eylea orders if gGastro is primarily a GI EMR?

Klivira integrates with gGastro via ModMed APIs, allowing it to intercept and process prior authorization requests for any medication ordered, including specialty drugs like Eylea. Our platform is designed to abstract PA workflows from EMR specialty focus, ensuring consistent processing even for drugs outside gGastro's primary gastroenterology scope.

What specific data points does Klivira extract from gGastro for Eylea PAs?

Klivira's intelligent engine extracts critical clinical data from gGastro, such as relevant ICD-10 codes for indications like wet AMD or DME, visual acuity measurements, OCT findings, and documentation of prior anti-VEGF therapies. This ensures comprehensive data submission for Eylea's medical necessity review, regardless of where these details are documented within the EMR.

Does Klivira support both medical and pharmacy benefit PAs for Eylea?

Eylea (aflibercept) is predominantly a buy-and-bill drug covered under the medical benefit. Klivira accurately identifies this, initiating medical benefit prior authorizations via X12 278 transactions. While Eylea is not typically a pharmacy benefit drug, Klivira supports both pathways for other medications, ensuring correct submission based on drug and payer specifics.

How does Klivira integrate with ModMed APIs for Eylea prior authorizations?

Klivira leverages established ModMed APIs to ensure seamless data exchange with gGastro. This integration allows Klivira to automatically detect Eylea orders, pull relevant patient demographics and clinical documentation, and push PA status updates back into the EMR, streamlining the entire prior authorization lifecycle.

Can Klivira help track Eylea PA status after submission?

Yes, Klivira provides real-time tracking of Eylea prior authorization status post-submission. Our platform integrates with payer portals and ePA systems (e.g., Da Vinci PAS) to provide continuous updates, reducing the administrative burden of manual follow-up for prior authorization coordinators and accelerating the approval process.

Related coverage

Other modernizing-medicine-gastro prior auth coverage

Ready to automate prior auth for this integration?

See how Klivira automates prior authorizations for your team.

Request a demo